Presented by the Washington Legal Foundation and Morrison & Foerster LLP

In recent years, the United States Department of Justice has prioritized the investigation and prosecution of pharmaceutical and life sciences companies for unlawful promotion and marketing of products for off-label use. What types of conduct and activities has the government targeted? What measures should companies adopt to prevent and defend itself and its employees against government investigations and prosecutions?

Our presenters have successfully defended companies and individuals in these cases at both the pre-indictment and trial stages and will address the following topics:

• Assessment of recent off-label criminal settlements, trials, and ongoing federal actions.
  
• Evolution of legal theory underlying government and private False Claims Act cases and effective defense strategies.
  
• Lessons health care companies can learn from off-label suits and settlements when designing compliance programs.
  
• Possible impact new law enforcers and health care reform will have on off-label communications and enforcement.

Who Should Attend:

• In-house counsel, compliance officers, regulatory managers, marketing/sales executives, and officers/directors from life sciences and pharmaceutical companies
  
• Outside counsel

To view the live webcast, please go to http://www.wlf.org.

If you have questions for the speakers, please email them to for answers during the webcast.